Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

S&P Healthcare Services SPDR (XHS)

S&P Healthcare Services SPDR (XHS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Price/Earnings ttm 15.31
  • Annual Dividend & Yield 0.28 (0.30%)
  • Most Recent Dividend 0.060 on 06/23/25
  • Management Fee 0.35%
  • INDUSTRY GROUPING:

    ETFs - Healthcare

Price Performance

See More
Period Period Low Period High Performance
1-Month
92.78 +0.22%
on 07/16/25
100.34 -7.34%
on 07/01/25
-3.35 (-3.48%)
since 06/17/25
3-Month
89.58 +3.80%
on 04/21/25
101.07 -8.00%
on 05/20/25
-1.22 (-1.30%)
since 04/17/25
52-Week
88.94 +4.54%
on 12/20/24
103.50 -10.16%
on 01/30/25
-2.78 (-2.90%)
since 07/17/24

Most Recent Stories

More News
How Is Cardinal Health’s Stock Performance Compared to Other Health Care Service Stocks?

Cardinal Health has outperformed its healthcare service peers over the past year, with analysts maintaining a positive outlook on its continued growth trajectory.

XHS : 92.98 (-0.25%)
COR : 294.38 (-1.16%)
CAH : 159.46 (-1.02%)
How Is Elevance Health's Stock Performance Compared to Other Healthcare Services Stock?

Elevance Health has notably underperformed other healthcare services stocks over the past year, yet analysts remain strongly bullish on the stock’s prospects.

XHS : 92.98 (-0.25%)
CI : 298.28 (-2.47%)
ELV : 302.45 (-12.22%)
Are Wall Street Analysts Predicting Henry Schein Stock Will Climb or Sink?

Although Henry Schein has underperformed the broader market over the past year, analysts remain cautiously optimistic about its long-term prospects.

XHS : 92.98 (-0.25%)
HSIC : 69.50 (+0.26%)
$SPX : 6,297.36 (+0.54%)
The Cigna Group Stock Outlook: Is Wall Street Bullish or Bearish?

The Cigna Group has struggled to keep pace with the broader market over the past year, yet Wall Street remains highly optimistic on its future prospects.

XHS : 92.98 (-0.25%)
CI : 298.28 (-2.47%)
$SPX : 6,297.36 (+0.54%)
Cardinal Health Stock Outlook: Is Wall Street Bullish or Bearish?

Cardinal Health has delivered robust gains over the past year, outperforming the broader market, and analysts are highly bullish on its outlook.

XHS : 92.98 (-0.25%)
$SPX : 6,297.36 (+0.54%)
MS : 140.90 (+0.79%)
CAH : 159.46 (-1.02%)
DaVita Stock Outlook: Is Wall Street Bullish or Bearish?

DaVita has underperformed the broader market over the past year, and analysts are cautious about the stock’s prospects.

XHS : 92.98 (-0.25%)
BCS : 19.01 (+1.49%)
$SPX : 6,297.36 (+0.54%)
DVA : 143.38 (+2.25%)
How Is DaVita's Stock Performance Compared to Other Health Care Services Stocks?

DaVita has underperformed the health care services industry this year, and analysts are cautious about the stock’s prospects.

XHS : 92.98 (-0.25%)
FMS : 26.99 (-0.88%)
DVA : 143.38 (+2.25%)
How Is Molina Healthcare's Stock Performance Compared to Other Health Care Services Stocks?

Despite Molina Healthcare’s recent underperformance relative to its industry peers, analysts remain moderately optimistic about the stock’s prospects.

XHS : 92.98 (-0.25%)
MOH : 204.25 (-5.47%)
UNH : 288.07 (-1.51%)
Are Wall Street Analysts Bullish on Quest Diagnostics Stock?

Quest Diagnostics has outperformed the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects.

XHS : 92.98 (-0.25%)
DGX : 168.18 (+0.69%)
$SPX : 6,297.36 (+0.54%)
MFG : 5.60 (+1.45%)
Is Wall Street Bullish or Bearish on Henry Schein Stock?

Henry Schein has trailed the broader market over the past year, yet analysts maintain a cautiously optimistic outlook on its future performance.

XHS : 92.98 (-0.25%)
KKR : 147.60 (+3.18%)
HSIC : 69.50 (+0.26%)
WFC : 79.71 (-0.25%)
$SPX : 6,297.36 (+0.54%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Fund Summary

The SPDR SP Health Care Services ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of SP Health Care Services Select Industry Index.

See More

Key Turning Points

3rd Resistance Point 93.58
2nd Resistance Point 93.38
1st Resistance Point 93.18
Last Price 92.98
1st Support Level 92.78
2nd Support Level 92.58
3rd Support Level 92.38

See More

52-Week High 103.50
Fibonacci 61.8% 97.94
Fibonacci 50% 96.22
Fibonacci 38.2% 94.50
Last Price 92.98
52-Week Low 88.94

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar